Surgical treatment of ischemic mitral valve regurgitation
10.3760/cma.j.issn.1001-4497.2018.07.015
- VernacularTitle:缺血性二尖瓣反流的外科治疗
- Author:
Changsheng ZHU
1
;
Shuiyun WANG
;
Hao CUI
;
Bing TANG
;
Shengwei WANG
Author Information
1. 中国医学科学院 北京协和医学院 国家心血管病中心 阜外医院心外科
- From:
Chinese Journal of Thoracic and Cardiovascular Surgery
2018;34(7):438-440
- CountryChina
- Language:Chinese
-
Abstract:
The ischemic mitral regurgitation( IMR) is present in 20% to 30% of patients with old myocardial infarction. In patients with heart failure after myocardial infarction , the incidence of IMR is even as high as 50%.IMR has adverse effects on the prognosis of patients and is positively correlated with the degree of reflux , including increased risk of heart failure and mortality of cardiovascular disease.Patients with severe hemodynamic abnormalities, and in the case of have accepted the best drug treatment is still difficult to alleviate symptoms of heart failure , surgical treatment should be implemented.However, the surgical treatment strategy of IMR is still controversial, that is, for the moderate IMR, only the blood transport reconstruction is sufficient to restore the natural form of the valve, whether the valve operation needs to be performed simultaneously ; In the case of severe IMR, simultaneous valvular surgery has been agreed upon.The controversy is that the mitral valve repair(MVP) and mitral valve replacement(MVR) are both superior and inferior.The purpose of this paper is to review the literature on IMR sur-gery in order to help us understand this important question.
